Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)
US6759192B1 · kind B1 · utility
4Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 1999 |
| Grant date | Jul 6, 2004 |
| Priority date | — |
| Expiry date | Jun 4, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B20/40
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
The invention concerns the geNo.mic sequence and cDNA sequences of the PCTA-1 gene. The invention also concerns biallelic markers of the PCTA-1 gene and the association established between these markers and prostate cancer. The invention provides means to determine the predisposition of individuals to prostate cancer as well as means for the diagNo.sis of prostate cancer and for the progNo.sis/detection of an eventual treatment response to agents acting against prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.